Breaking News

Symbiosis Completes 1,000th Batch of Injectable Drug Product

Supports clinical development and commercial supply across a range of therapeutic areas.

Symbiosis Pharmaceutical Services, a global CMO, has successfully completed its 1,000th sterile drug product batch. The company supports clients through phase I, II and III clinical trials and commercial-scale manufacturing. Since the company was founded in 2011, Symbiosis has grown from a Scottish startup into an internationally recognized sterile manufacturer of injectable drug products, supporting both clinical development and commercial supply across a wide range of therapeutic areas. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters